CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Atyr Pharma Inc   (LIFE)
Other Ticker:  
 
 

LIFE's Revenue Growth by Quarter and Year

Atyr Pharma Inc 's Revenue results by quarter and year




LIFE Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 10.39 0.00 2.05
III Quarter September - 0.00 0.00 0.15
II Quarter June 0.00 0.00 0.00 0.19
I Quarter March 0.00 0.00 0.00 8.07
FY   0.00 10.39 0.00 10.46



LIFE Revenue second quarter 2023 Y/Y Growth Comment
Atyr Pharma Inc in the second quarter 2023 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2023, Atyr Pharma Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Atyr Pharma Inc ' s Revenue no change of % ranks overall at the positon no. in the second quarter 2023.


LIFE Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - 1364.29 %
III Quarter September - - - -16.67 %
II Quarter June - - - 111.11 %
I Quarter March - - - -
FY   - - - 2451.22 %

Financial Statements
Atyr Pharma Inc 's second quarter 2023 Revenue $ 0.00 millions LIFE's Income Statement
Atyr Pharma Inc 's second quarter 2022 Revenue $ 0.00 millions Quarterly LIFE's Income Statement
New: More LIFE's historic Revenue Growth >>


LIFE Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - 1266.67 %
III Quarter September - - - -21.05 %
II Quarter June - - - -97.65 %
I Quarter March - - - 5664.29 %
FY (Year on Year)   - - - 2451.22 %


Explore LIFE Customer Growth by Product and Service >> Back to LIFE Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Atyr Pharma Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LIFE's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LIFE's II. Quarter Q/Q Revenue Comment


Atyr Pharma Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #

New: More LIFE's historic Revenue Growth >>



Cumulative Revenue growth Comment
In the Jun 30 2023 period, Atyr Pharma Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Atyr Pharma Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2023 period, Atyr Pharma Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Atyr Pharma Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LIFE's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LIFE's Competitors
Revenue Growth for Atyr Pharma Inc 's Suppliers
Revenue Growth for LIFE's Customers

You may also want to know
LIFE's Annual Growth Rates LIFE's Profitability Ratios LIFE's Asset Turnover Ratio LIFE's Dividend Growth
LIFE's Roe LIFE's Valuation Ratios LIFE's Financial Strength Ratios LIFE's Dividend Payout Ratio
LIFE's Roa LIFE's Inventory Turnover Ratio LIFE's Growth Rates LIFE's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Aquestive Therapeutics Inc -0.18%$ -0.181 millions
Phibro Animal Health Corporation-0.34%$ -0.340 millions
Amedisys Inc-0.88%$ -0.882 millions
Baxter International Inc -1.04%$ -1.041 millions
Healthcare Services Group Inc -1.39%$ -1.395 millions
Bio rad Laboratories Inc -1.54%$ -1.536 millions
Harvard Bioscience Inc-1.83%$ -1.832 millions
Embecta Corp -1.92%$ -1.924 millions
Enhabit Inc -2.13%$ -2.127 millions
Icu Medical Inc-2.26%$ -2.260 millions
Tandem Diabetes Care Inc -2.26%$ -2.261 millions
West Pharmaceutical Services Inc -2.27%$ -2.269 millions
Coherus Biosciences inc -2.39%$ -2.386 millions
Hookipa Pharma inc -2.44%$ -2.440 millions
Biolife Solutions Inc -2.53%$ -2.529 millions
Inspiremd Inc -2.61%$ -2.613 millions
Enanta Pharmaceuticals Inc-3.01%$ -3.014 millions
National Research Corporation-3.03%$ -3.033 millions
Intellia Therapeutics Inc -3.11%$ -3.108 millions
Orgenesis Inc -3.14%$ -3.138 millions
Organogenesis Holdings Inc -3.36%$ -3.365 millions
Marker Therapeutics inc -3.52%$ -3.523 millions
Akumin Inc -3.79%$ -3.793 millions
Endo International Plc-3.91%$ -3.912 millions
Zimvie Inc -4.12%$ -4.122 millions
Integra Lifesciences Holdings Corp-4.16%$ -4.160 millions
Universal Biosensors Inc -4.18%$ -4.177 millions
Sonendo Inc -4.26%$ -4.257 millions
Avinger Inc -4.27%$ -4.268 millions
Fuse Medical Inc -4.27%$ -4.271 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com